概述
-
货号
FHB96210
-
种属反应性
Human -
宿主
Mouse -
同种型
IgG2b -
克隆类型
Monoclonal -
偶联物
Unconjugated -
靶标
T cell receptor alpha chain constant, TRAC, TCRA -
浓度
3.14 mg/ml -
内毒素水平
Please contact with the lab for this information. -
纯度
>95% as determined by SDS-PAGE. -
纯化方式
Protein A/G purified from cell culture supernatant. -
Accession号
P01848 -
克隆号
T10B9.1A-31
-
应用
FCM -
状态
Liquid -
保存溶液
0.01M PBS, pH 7.4. -
稳定性和存储
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
图片
参考文献
- Complement-mediated T-cell depletion of bone marrow: comparison of T10B9. 1A-31 and Muromonab-Orthoclone OKT3
- T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
- TREATMENT OF RENAL ALLOGRAFT REJECTION WITH T10B9. 1A31 OR OKT3: Final Analysis of a Phase II Clinical Trial: 1
- TREATMENT OF ACUTE CELLULAR REJECTION WITH T10B9. 1A-31 OR OKT3 IN RENAL ALLOGRAFT RECIPIENTS1
- A new limiting dilution culture system for the detection of T cell subsets in T cell-depleted marrow grafts
- Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients
- T10B9. 1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
- Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells
- Induction immunotherapy in heart transplantation with T10B9. 1A-31: a phase I study.
- Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9. 1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective …
评价
